These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8831367)

  • 1. Effect of doxazosin on fibrinolysis in hypertensive patients with and without insulin resistance.
    Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
    Am Heart J; 1996 Oct; 132(4):783-9. PubMed ID: 8831367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired fibrinolysis and insulin resistance in patients with hypertension.
    Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
    Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters.
    Zehetgruber M; Christ G; Gabriel H; Mundigler G; Beckmann R; Binder BR; Huber K
    Thromb Haemost; 1998 Feb; 79(2):378-82. PubMed ID: 9493594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men.
    Andersen P; Seljeflot I; Herzog A; Arnesen H; Hjermann I; Holme I
    J Cardiovasc Pharmacol; 1998 May; 31(5):677-83. PubMed ID: 9593066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.
    Jansson JH; Johansson B; Boman K; Nilsson TK
    Eur J Clin Pharmacol; 1991; 40(4):321-6. PubMed ID: 1828764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
    Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and metabolic effects of doxazosin in hypertensive patients with concomitant non-insulin-dependent diabetes mellitus.
    Inoue Y; Kaku K; Kaneko T; Matsumura S; Nakayama H; Yoshizaki Y; Ando S; Inoue M; Hatao M
    J Int Med Res; 1996; 24(1):138-46. PubMed ID: 8674792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of doxazosin and hydralazine on insulin sensitivity and sympathetic function in spontaneously hypertensive rat (SHR)].
    Takahashi A; Kushiro T; Kanmatsuse K
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):240-4. PubMed ID: 9654906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose, insulin, and lipid metabolism in doxazosin-treated patients with hypertension.
    Shieh SM; Sheu WH; Shen DC; Fuh MM; Chen YD; Reaven GM
    Am J Hypertens; 1992 Nov; 5(11):827-31. PubMed ID: 1457085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine.
    De Luca N; Izzo R; Fontana D; Iovino G; Argenziano L; Vecchione C; Trimarco B
    J Hypertens; 2000 Oct; 18(10):1515-22. PubMed ID: 11057441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenoreceptors, endothelial function, and lipid profile: effects of atenolol, doxazosin, and carvedilol.
    González Maqueda I
    Coron Artery Dis; 1994 Nov; 5(11):909-18. PubMed ID: 7719523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between endothelial function and fibrinolysis in early hypertension.
    Tomiyama H; Kimura Y; Mitsuhashi H; Kinouchi T; Yoshida H; Kushiro T; Doba N
    Hypertension; 1998 Jan; 31(1 Pt 2):321-7. PubMed ID: 9453323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H
    Nephrology (Carlton); 2010 Mar; 15(2):211-5. PubMed ID: 20470281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.
    Rautio A; Boman K; Gerstein HC; Hernestål-Boman J; Lee SF; Olofsson M; Mellbin LG
    Diab Vasc Dis Res; 2017 Jul; 14(4):345-352. PubMed ID: 28403644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of doxazosin, an alpha 1-blocker, on serum lipids in hypertensive patients.
    Ishimitsu T; Yagi S; Sugishita Y; Fujimura A; Ebihara A; Sakamaki T; Murata K; Saito A
    Hypertens Res; 1996 Mar; 19(1):43-9. PubMed ID: 8829823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of doxazosin therapy on glucose tolerance and lipid metabolism in hypertensive patients with impaired glucose tolerance.
    Shionoiri H; Ashino K; Yamanaka K; Shindo K; Hiroto S; Arita T
    Clin Ther; 1997; 19(3):527-36. PubMed ID: 9220217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
    Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
    Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.